T0	Interventions 0 33	Liposome-encapsulated doxorubicin
T1	Interventions 48 72	conventional doxorubicin
T2	Interventions 249 338	liposome-encapsulated doxorubicin, TLC D-99 (Myocet, Elan Pharmaceuticals, Princeton, NJ)
T3	Interventions 344 368	conventional doxorubicin
T4	Interventions 559 595	TLC D-99 (75 mg/m(2)) or doxorubicin
T5	Interventions 939 989	multiple-gated radionuclide cardioangiography scan
T6	Interventions 1528 1547	doxorubicin-treated
T7	Interventions 1674 1685	doxorubicin
T8	Interventions 1741 1752	doxorubicin
T9	Interventions 1805 1813	TLC D-99
T10	Interventions 1837 1848	doxorubicin
T11	Interventions 2006 2018	doxorubicin.
T12	Interventions 2099 2110	doxorubicin
T13	Interventions 2385 2397	doxorubicin.
T14	Interventions 2423 2431	TLC D-99
T15	Interventions 2466 2477	doxorubicin